Clinical Cancer Drugs


Giulio Francia
Department of Biological Sciences
The University of Texas
El Paso, TX

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 3 Issue: 1, May 2016

Preface: free to download

Volume:3   Issue: 1
Pp: 1-1
Yuval Shaked
DOI: 10.2174/2212697X0301160328195646
Published on: 28 March, 2016

Editorial (Thematic Issue: Novel Therapeutic Strategies for Castration-resistant Prostate Cancer: Update and Future Perspectives) free to download

Volume:3   Issue: 1
Pp: 2-5
Patrizia Limonta
DOI: 10.2174/2212697X0301160328195947
Published on: 28 March, 2016

Prostate Cancer Molecular Background: The IGF-1Ec Story

Volume:3   Issue: 1
Pp: 6-15
Armakolas Athanasios and Koutsilieris Michael
DOI: 10.2174/2212697X03666151203202720
Published on: 03 December, 2015

Castration-resistant Prostate Cancer: The Targeting of Bone Microenvironment-related Survival Factors For Prostate Cancer Cells

Volume:3   Issue: 1
Pp: 16-22
Dimitrios Karamanolakis, Athanasios Armakolas and Michael Koutsilieris
DOI: 10.2174/2212697X03666151203202934
Published on: 03 December, 2015

Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer

Volume:3   Issue: 1
Pp: 23-35
Lavinia Casati, Fabio Celotti and Valeria Sibilia
DOI: 10.2174/2212697X03666151207185452
Published on: 07 December, 2015

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

Volume:3   Issue: 1
Pp: 36-62
Festuccia Claudio
DOI: 10.2174/2212697X0301160328201324
Published on: 28 March, 2016

Medicinal Compound Celastrol As a Potential Clinical Anticancer Drug: Lessons Learned From Preclinical Studies

Volume:3   Issue: 1
Pp: 63-73
Jianquan Wu, Chengcheng Hong, Hongjie Pan, Qingzhu Yang, Yu Mei, Q. Ping Dou and Huanjie Yang
DOI: 10.2174/2212697X03666160112001739
Published on: 11 January, 2016